ARK 每周股评 – 1/15/2022


We share weekly commentaries with investors on stocks in our strategies that have appreciated or dropped more than 15% in a day during the course of the week. We hope you find this commentary useful.

CareDx (CDNA)
+18%CareDx (CDNA), an industry leader in supporting transplant procedures and monitoring/aiding outcomes, traded up 18% on Monday after preannouncing much stronger than expected financial results for the fourth quarter and better than expected guidance for 2022.

注: CareDx (CDNA)是支持移植手术和监测/帮助结果的行业领导者,在预宣布第四季度的财务业绩远高于预期和2022年的指导意见后,周一交易上涨18%。
Accolade (ACCD)
+25%Accolade (ACCD), a leading company in healthcare benefits management, traded up over 25% on Tuesday after announcing positive financial results for its fiscal third quarter as it continues along a path to profitability.

注: 医疗保健福利管理的领先公司Accolade(ACCD)在宣布第三财季积极的财务业绩后,周二交易价格上涨超过25%,该公司继续沿着盈利的道路前进。
Butterfly Network (BFLY)
+19%Butterfly Network (BFLY), a leader in the medical imaging field, traded up 19% on Tuesday after announcing that the Rochester Medical Group will deploy Butterfly’s technology throughout its enterprise.

注: 医学成像领域的领导者Butterfly Network(BFLY)在宣布罗切斯特医疗集团将在整个企业中部署Butterfly的技术后,周二交易量上升了19%。
Nurix Therapeutics (NRIX)
-15%Nurix Therapeutics (NRIX), a leading company in the emerging targeted protein therapeutics (TPD) space, traded down 15% on Tuesday after announcing a slight delay in the release of clinical data.

注: Nurix Therapeutics(NRIX)是新兴的靶向蛋白疗法(TPD)领域的一家领先公司,在宣布略微推迟发布临床数据后,周二交易价格下跌了15%。


上一篇 2022年1月15日 上午8:54
下一篇 2022年1月19日 下午2:14



您的电子邮箱地址不会被公开。 必填项已用*标注